Tolerability and efficacy of targeting both mTOR and HER2 signaling in trastuzumab-refractory HER2+ metastatic breast cancer Meeting Abstract


Authors: Gajria, D.; King, T.; Pannu, H.; Sakr, R.; Modi, S.; Drullinsky, P.; Syldor, A.; Patil, S.; Seidman, A.; Norton, L.; Rosen, N.; Hudis, C.; Chandarlapaty, S.
Abstract Title: Tolerability and efficacy of targeting both mTOR and HER2 signaling in trastuzumab-refractory HER2+ metastatic breast cancer
Meeting Title: 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 72
Issue: 24 Suppl.
Meeting Dates: 2012 Dec 4-8
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2012-12-15
Language: English
ACCESSION: WOS:000209704901244
DOI: 10.1158/0008-5472.sabcs12-p5-18-04
PROVIDER: wos
Notes: Meeting Abstract: P5-18-04 -- Source: Wos
Altmetric Score
MSK Authors
  1. Sujata Patil
    367 Patil
  2. Andrew D Seidman
    238 Seidman
  3. Clifford Hudis
    819 Hudis
  4. Larry Norton
    544 Norton
  5. Neal Rosen
    352 Rosen
  6. Harpreet Pannu
    19 Pannu
  7. Tari King
    161 King
  8. Devika Gajria
    22 Gajria
  9. Shanu Modi
    128 Modi
  10. Rita Sakr
    58 Sakr
  11. Angemael   Syldor
    3 Syldor